AT1a receptor signaling is required for basal and water deprivation-induced urine concentration in AT1a receptor-deficient mice

American Journal of Physiology - Renal Physiology

Volumn 303, Issue 5, 2012, Pages

  Li, Xiao C ^a   Shao, Yuan ^a   Zhuo, Jia L ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclases; Angiotensin II; Angiotensin II type 1a receptor; Aquaporin 2; Arginine vasopressin; Inner medullary collecting ducts; Urine concentration

Indexed keywords

ADENYLATE CYCLASE; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; AQUAPORIN 2; ARGIPRESSIN; CYCLIC AMP; DESMOPRESSIN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POTASSIUM; SODIUM; ADENYLATE CYCLASE 3; AGTR1A PROTEIN, MOUSE; ANGIOTENSIN 1 RECEPTOR; AQP2 PROTEIN, MOUSE; ARGIPRESSIN[1 DEAMINO];

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; KIDNEY CONCENTRATING CAPACITY; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MOUSE; NONHUMAN; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; URINE OSMOLALITY; WATER DEPRIVATION; WILD TYPE; ANIMAL; BLOOD; BLOOD PRESSURE; METABOLISM; OSMOLARITY; PHYSIOLOGY;

ADENYLATE CYCLASE; ANIMALS; AQUAPORIN 2; ARGININE VASOPRESSIN; BLOOD PRESSURE; DEAMINO ARGININE VASOPRESSIN; LOSARTAN; MALE; MAP KINASE SIGNALING SYSTEM; MICE; OSMOLAR CONCENTRATION; RECEPTOR, ANGIOTENSIN, TYPE 1; WATER DEPRIVATION;

EID: 84865714950     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00644.2011     Document Type: Article

References (50)

1. Bek MJ, Zheng S, Xu J, Yamaguchi I, Asico LD, Sun XG, Jose PA. Differential expression of adenylyl cyclases in the rat nephron. Kidney Int 60: 890-899, 2001.
2. Carmosino M, Brooks HL, Cai Q, Davis LS, Opalenik S, Hao C, Breyer MD. Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct. Am J Physiol Renal Physiol 292: F351-F360, 2007.
3. Cervenka L, Mitchell KD, Oliverio MI, Coffman TM, Navar LG. Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions. Kidney Int 56: 1855-1862, 1999.
4. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol Renal Physiol 272: F299-F304, 1997.
5. + stores and calmodulin. J Biol Chem 275: 36839-36846, 2000.
6. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
7. Dunn FL, Brennan TJ, Nelson AE, Robertson GL. The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 2: 3212-3219, 1973.
8. Ecelbarger CA, Chou CL, Lolait SJ, Knepper MA, DiGiovanni SR. Evidence for dual signaling pathways for V2 vasopressin receptor in rat inner medullary collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 270: F623-F633, 1996.
9. Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, Bernstein KE. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 99: 2375-2385, 1997.
10. Fenton RA, Knepper MA. Mouse models and the urinary concentrating mechanism in the new millennium. Physiol Rev 87: 1083-1112, 2007.
11. Goel M, Sinkins WG, Zuo CD, Hopfer U, Schilling WP. Vasopressininduced membrane trafficking of TRPC3 and AQP2 channels in cells of the rat renal collecting duct. Am J Physiol Renal Physiol 293: F1476-F1488, 2007.
12. Gohlke P, Von KS, Jurgensen T, Kox T, Rascher W, Culman J, Unger T. Effects of orally applied candesartan cilexetil on central responses to angiotensin II in conscious rats. J Hypertens 20: 909-918, 2002.
13. Gonzalez CB, Herrera VL, Ruiz-Opazo N. Renal immunocytochemical distribution and pharmacological properties of the dual angiotensin II/AVP receptor. Hypertension 29: 957-961, 1997.
14. Hoffert JD, Chou CL, Fenton RA, Knepper MA. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J Biol Chem 280: 13624-13630, 2005.
15. Hoffert JD, Chou CL, Fenton RA, Knepper MA. Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct. J Biol Chem 280: 13624-13630, 2005.
16. Hogarty DC, Tran DN, Phillips MI. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin. Brain Res 637: 126-132, 1994.
17. Howard RL, Bichet DG, Schrier RW. Hypernatremic and polyuric states. In: The Kidney: Physiology and Pathophysiology (2nd ed.), edited by Seldin DW, Giebisch G. New York: Raven, 1992, p. 1753-1778.
18. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92: 3521-3525, 1995.
19. Katsura T, Gustafson CE, Ausiello DA, Brown D. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am J Physiol Renal Physiol 272: F817-F822, 1997.
20. Kihara M, Umemura S, Sumida Y, Yokoyama N, Yabana M, Nyui N, Tamura K, Murakami K, Fukamizu A, Ishii M. Genetic deficiency of angiotensinogen produces an impaired urine concentrating ability in mice. Kidney Int 53: 548-555, 1998.
21. Klingler C, Ancellin N, Barrault MB, Morel A, Buhler JM, Elalouf JM, Clauser E, Lugnier C, Corman B. Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT1A and V2 receptors. Cell Signal 10: 65-74, 1998.
22. Klussmann E, Maric K, Wiesner B, Beyermann M, Rosenthal W. Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem 274: 4934-4938, 1999.
23. Knepper MA. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol Renal Physiol 272: F3-F12, 1997.
24. Kwon TH, Nielsen J, Knepper MA, Frokiaer J, Nielsen S. Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats. Am J Physiol Renal Physiol 288: F673-F684, 2005.
25. Lee YJ, Song IK, Jang KJ, Nielsen J, Frokiaer J, Nielsen S, Kwon TH. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Am J Physiol Renal Physiol 292: F340-F350, 2007.
26. Li XC, Campbell DJ, Ohishi M, Shao Y, Zhuo JL. AT1 receptoractivated signaling mediates angiotensin IV-induced responses in renal microvasculature and glomerular mesangial cells. Am J Physiol Renal Physiol 290: F1024-F1033, 2006.
27. Li XC, Carretero OA, Shao Y, Zhuo JL. Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C. Hypertension 47: 580-585, 2006.
28. Li XC, Carretero OA, Zhuo JL. Cross-talk between angiotensin II and glucagon receptor signaling mediates phosphorylation of mitogen-activated protein kinase ERK1/2 in rat glomerular mesangial cells. Biochem Pharmacol 71: 1711-1719, 2006.
29. Li XC, Navar LG, Shao Y, Zhuo JL. Genetic deletion of AT1a receptors attenuates intracellular accumulation of angiotensin II in the kidney of AT1a receptor-deficient mice. Am J Physiol Renal Physiol 293: F586-F593, 2007.
30. Li XC, Shao Y, Zhuo JL. AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla. Kidney Int 76: 169-177, 2009.
31. 5-ANG II in the kidneys and adrenal glands of AT1a receptor-deficient mice. Am J Physiol Renal Physiol 294: F293-F302, 2008.
32. 5-Ang II endocytosis and NHE-3 expression in immortalized rabbit proximal tubule cells. Am J Physiol Cell Physiol 293: C367-C378, 2007.
33. McKinley MJ, Johnson AK. The physiological regulation of thirst and fluid intake. News Physiol Sci 19: 1-6, 2004.
34. Morris M, Li P, Callahan MF, Oliverio MI, Coffman TM, Bosch SM, Diz DI. Neuroendocrine effects of dehydration in mice lacking the angiotensin AT1a receptor. Hypertension 33: 482-486, 1999.
35. Morris M, Means S, Oliverio MI, Coffman TM. Enhanced central response to dehydration in mice lacking angiotensin AT1a receptors. Am J Physiol Regul Integr Comp Physiol 280: R1177-R1184, 2001.
36. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82: 205-244, 2002.
37. Oliverio MI, Delnomdedieu M, Best CF, Li P, Morris M, Callahan MF, Johnson GA, Smithies O, Coffman TM. Abnormal water metabolism in mice lacking the type 1A receptor for ANG II. Am J Physiol Renal Physiol 278: F75-F82, 2000.
38. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, Coffman TM. Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A 95: 15496-15501, 1998.
39. Oliverio MI, Madsen K, Best CF, Ito M, Maeda N, Smithies O, Coffman TM. Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol Renal Physiol 274: F43-F50, 1998.
40. Robertson GL. Regulation of vasopressin secretion. In: The Kidney: Physiology and Pathophysiology (2nd ed.), edited by Seldin DW, Giebisch G. New York: Raven, 1992, p. 1595-1613.
41. Sanvitto GL, Jöhren O, Häuser W, Saavedra JM. Water deprivation upregulates ANG II AT1 binding and mRNA in rat subfornical organ and anterior pituitary. Am J Physiol Endocrinol Metab 273: E156-E163, 1997.
42. Shi L, Hu F, Morrissey P, Yao J, Xu Z. Intravenous angiotensin induces brain c-fos expression and vasopressin release in the near-term ovine fetus. Am J Physiol Endocrinol Metab 285: E1216-E1222, 2003.
43. Stegbauer J, Gurley SB, Sparks MA, Woznowski M, Kohan DE, Yan M, Lehrich RW, Coffman TM. AT1 receptors in the collecting duct directly modulate the concentration of urine. J Am Soc Nephrol 22: 2237-2246, 2011.
44. Takahashi N, Lopez ML, Cowhig JE Jr, Taylor MA, Hatada T, Riggs E, Lee G, Gomez RA, Kim HS, Smithies O. Renlc homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J Am Soc Nephrol 16: 125-132, 2005.
45. Tian Y, Sandberg K, Murase T, Baker EA, Speth RC, Verbalis JG. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis. Endocrinology 141: 307-314, 2000.
46. Touyz RM, El Mabrouk M, He G, Wu XH, Schiffrin EL. Mitogenactivated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ Res 84: 505-515, 1999.
47. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, Ichikawa I. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998.
48. Yang B, Zhao D, Qian L, Verkman AS. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion. Am J Physiol Renal Physiol 291: F465-F472, 2006.
49. Zhuo J, Allen AM, Alcorn D, MacGregor D, Aldred GP, Mendelsohn FA. The distribution of angiotensin II receptors. In: Hypertension: Pathology, Diagnosis & Management (2nd ed.), edited by Laragh JH, Brenner BM. New York: Raven, 1995, p. 1739-1762.
50. Zhuo JL. Renomedullary interstitial cells: a target for endocrine and paracrine actions of vasoactive peptides in the renal medulla. Clin Exp Pharmacol Physiol 27: 465-473, 2000